Sulfur mustard (SM), commonly known as mustard gas, represents a highly potent vesicant and chemical warfare agent with a long history of inflicting severe cutaneous injuries. This thesis delves into the intricate and multifaceted realm of the biological activities exhibited by the products arising from the interaction of mustard gas with human skin tissues, with a particular emphasis on elucidating the underlying biochemical mechanisms. Our investigative approach comprises a sophisticated integration of cutting-edge analytical techniques, driven by a relentless pursuit of precision in understanding this complex toxicological interplay. High-resolution mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and gas chromatography-mass spectrometry (GC-MS) have been meticulously employed to meticulously identify, characterize, and quantify the diverse chemical intermediates and end products formed during the interaction between mustard gas and human skin tissues. By doing so, we aim to establish a comprehensive and definitive chemical profile of the interaction products. At the heart of this study lies a rigorous exploration of the consequences of these chemical interactions on human skin cells and tissues. Our endeavors extend to the implementation of in vitro models and advanced cell culture systems, which provide an invaluable platform for assessing the effects of mustard gas and its derivatives. Through comprehensive histopathological analyses, we meticulously delineate the cellular responses, tissue damage, and molecular alterations induced by these interaction products. The synthesis of these endeavors unravels the intricate web of molecular and cellular events that transpire in response to mustard gas exposure. Our findings underscore the profound significance of understanding the biological activity of these interaction products, as it not only deepens our comprehension of the mechanisms behind mustard gas-induced skin injuries but also fosters the development of more effective therapeutic interventions and protective measures. Moreover, it facilitates the assessment of potential biomarkers for exposure and provides critical data for the design of countermeasures against mustard gas-related dermatological toxicity. In our pursuit of scientific rigor, we have consulted a rich array of primary research articles, reviews, and authoritative texts from prominent sources in the fields of toxicology, biochemistry, and chemical warfare agents, ensuring that our work remains firmly grounded in the current state of knowledge. With this expanded and refined abstract, we endeavor to encapsulate the breadth and depth of our research efforts and the profound implications of our findings in the field of biochemistry and toxicology. The interaction of sulfur mustard (SM), commonly referred to as mustard gas, with human skin tissues has long been a subject of grave concern and rigorous scientific investigation. This toxic agent, known for its blistering and cytotoxic properties, poses a significant threat in both military and civilian contexts, demanding a comprehensive understanding of its mechanisms of action. Mustard gas's historical use in warfare, as well as its potential for accidental or intentional exposure, underscores the importance of unraveling the intricate biological consequences of its interaction with the skin. Mustard gas, an alkylating agent, initiates a cascade of molecular events upon contact with human skin. The severity of its toxic effects, characterized by blister formation, erythema, and tissue necrosis, is a testament to the profound impact it has on the skin at various levels of biological organization. To appreciate the complexities inherent in this interaction, it is imperative to delve into the underlying biochemistry, toxicodynamics, and cellular responses that dictate the outcomes of exposure. The present study embarks on a scientific odyssey, aiming to dissect the biological activities of the products arising from the interaction of mustard gas with human skin tissues. Our research seeks to bridge the existing knowledge gaps in this domain, applying a multidisciplinary approach that spans biochemistry, toxicology, and analytical chemistry. To achieve this, we undertake an exhaustive analysis of the chemical intermediates and end products formed during the interaction, as well as a meticulous examination of their effects on human skin at the cellular and molecular levels. In this introduction, we offer a glimpse of the overarching objectives of our study, outlining the scientific rigor and comprehensive methodologies employed to investigate this complex phenomenon. The research unfolds in a series of interconnected steps, each designed to explore the nuances of mustard gas's interaction with human skin tissues comprehensively. These investigations lay the groundwork for a more profound understanding of the toxicological implications, which, in turn, inform the development of effective therapeutic strategies and protective measures against mustard gas exposure. Understanding the biological activity of the interaction products generated during mustard gas exposure is not only pivotal in the context of dermatotoxicity but also carries broader implications. Our research endeavors hold the potential to contribute significantly to the field of toxicology, offering critical insights into the mechanisms of action of chemical warfare agents, as well as potentially facilitating the development of diagnostic tools and medical countermeasures.

Keywords: Mustard Gas, Biological Effects, Genomic Mutations, Molecular Docking, Clinical Research, Military Intelligence, International Security, Environmental Impact.

[1] Jeffrey P. Koplan (2001). Draft Toxicological Profile for Mustard Gas. Prepared by: Syracuse Research Corporation, Under Contract No. 205-1999-00024, Prepared for: U.S. Department of Health and Human Services, Public Health Service Agency for Toxic Substances and Disease Registry, September 2001.

[2] Geoff Plunkett (2014). Death by Mustard Gas, How Military Secrecy and Lost Weapons can Kill. See National Library of Australia for Cataloguing-in-Publication entry ISBN: 9780987427915.

[3] William Jackson Pope & Charles Stanley (1918). Patent Specification. 142,875, Improvements in the production of b b-dichlorethyl sulphide. Application Date, Apr. 3 1918, No 5686/18, Marks & Clerck.

[4] Hendrick P. Benschop (1991). Grant No DAD 17-88-Z-80Z2. Verification, Dosimetry and Biomonitoring of Mustard Gas Exposure via Immunochemical Detection of Mustard Gas Adducts to DNA and Proteins. The Netherlands, Report Date: December 1991, Type of Report. U.S. Army Medical Research and Development Command, Fort Detrick Frederick, Maryland 21702-5012.

[5] Mostafa Ghanei (n.d.). Defense Technical Information Center Compilation Part Notice: Late Hematologic Complications of Mustard Gas. Approved for public release, distribution unlimited the following component part numbers comprise the compilation report: ADP013371 thru ADP013468, Unclassified.

[6] Alfred Scott Warthin & Carl Vernon Weller (1919). The Medical Aspects of Mustard Gas Poisoning. St. Louis C.V. Mosby Company.

[7] Ralph N. Harris III & Robert A. Sanderson (n.d.). Systemic Mustard Gas Scavengers. Systemic Mustard Gas Scavengers, Midterm Progress Report 3/5/90-3/4/91, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025-3493, U.S. Army Medical R&D Command, Fort Detrick. Frederic, MD 21702-5012.

[8] Reginald E. Bickerton (1934). Extract from British Medio Journal. Issue 27th October 1934, New Gases of War Blindness due to Mustard, Ophthalmic Surgeon, St. Dunstan's.

[9] G.V. Montgomery & Jim Slattery (1993). Department of Defence Mustard Gas Testing. Y 4. V 64/3: 103-3, March 10, 1993, Printed for the use of the Committee on Veterans' Affairs Serial No. 103-3, U.S. Government Printing Office Washington: 1993, For sale by the U.S. Government Printing Office Superintendent of Documents, Congressional Sales Office, Washington, DC 20402, ISBN 0-16-041187-4. 

[10] Peyton C. March & P.C. Harris (1920). Chemical Warfare Part VI, Defence against Gas. Revision of A. E. F. Publication No. 1433 January, 1920.Washington Government Printing Office.

[11] William S. Sibert (1919). An Historical Sketch of the Development of Hedgewood Arsenal. Approved for public release; distribution is unlimited, Document partially illegible, Distribution authorized to U.S. Gov't. agencies and their contractors; Administrative/Operational Use; 01 MAR 1919, Other requests shall be referred to Chemical Warfare Service, Edgewood Arsenal, MD.

[12] S.M. Wiseman, R.E. Arvidson, M.J. Wolff, M.D. Smith, F.P. Seelos, F. Morgan, S.L. Murchie, J.F. Mustard, R.V. Morris, D. Humm & P.C. McGuire (2014). Characterization of Artifacts Introduced by the Empirical Volcano-Scan Atmospheric Correction Commonly Applied to CRISM and OMEGA Near-Infrared Spectra. PII: S0019-1035(14)00551-X DOI: http://dx.doi.org/10.1016/j.icarus.2014.10.012.

[13] Josiah Macy (1939). Medical Manual of Chemical Warfare. London His Majesty’s Stationery Office, Crown Copyright Reserved.

[14] Tasker H. Bliss & H.P. McCain (1917). Program of Training in Gas Defence for Divisional in Anti-Gas School. Edited at Army War College, October, 1917, Washington Government Printing Office.

[15] H.G. Creedy (1926). Manual of the Medical Aspects of the Chemical Warfare, 1926. “The War Office, 6th August, 1926: London: Published by His Majesty’s Stationery Office, Rel ert Adastral House, Kingsway, London, W.C.2 ; York Street, Manchester; 1, St. Andrew’s Crescent, Cardiff; or 120, George Street, Edinburgh.

[16] H.G. Creedy (1937). An Atlas of Gas Poisoning. Second Edition, His Majesty’s Stationery Office, Crown Copyright Reserved.

[17] S.J.M. Auld (1918). Gas and Flame in Modern Warfare. By Major S. J. M. AULD, M.G. Hotal Berkshire Regiment, Member of the British Military Mission to the United States, Copyright By George H. Doran Company.

[18] James K. Senior (1950). Gas Warfare, With Special Reference to Defence of Middle East.

[19] G.C. Marshall & J.A. Ulio (1944). TM 8-617. War Department Technical Manual. Mask Type Oxygen Therapy Outfit, Complete, and Oxygen Therapy Outfit with Manifold, War Department.

[20] H.E. Howe (n.d.). An Exhibit, Prepared under the auspices of the National Research Council, With the Cooperation of the Chemical War Service of the United States Army. Now Permanently Installed at the Smithsonian Institute, Washington D.C. Library of the Congress, 0007299242 8.

[21] Leo P. Brophy & George J.B. Fisher (2004). United States Army in World War II. The Technical Services: The Chemical War Service Organizing for War, Center of Military History, United States Army. Washington, D.C.

[22] G.C. Marshall & J.A. Ulio (1944). FM 3-70. War Department Field Manual. Chemical Decontamination Company, War Department - 1 September 1944.

[23] Amos A. Fries & Clarence J. West (1921). Chemical Warfare. U.S.A. National Research Council. First Edition. McGraw-Hill Book Company, Inc.  New York: 370 Seventh Avenue London.

[24] Peter K. Raymore (1988). Air War College, Air University Chemical Weapon Treaty: Perspectives and Prospects, USAF Research Report Research Advisor: Dr. Robert A. Hoover. Maxwell Air Force Base, Alabama.

[25] Donald A. Cameron (n.d.). Chemical Warfare, International Pamphlets. 799 Broadway New York.

[26] Donald A. Cameron (1976). US Army Missile and Munition Center and School. Munitions Department. Redstone Arsenal, Alabama 35809, Chemical Munition EOD/TE Study Guide 1, Chemical Agents, Terms.

[27] R.C. Eley (1945). Report on Visit on Plants Ludvigshaven, Germany. 25 March 1945, Cios Black Last Item 24, Medicine, Combined Intelligence Objectives Sub-Commitee G-2 Division, Shaef (rear) APO 413.

[28] Sharon B. Campbell (1999). Naval War College. Newport, R.I. Chemical and Biological Warfare: Impact on Force Deployment, By Sharon B. Campbell, Commander USN, 17 May 1999, 19991122140.

[29] Davi M. D'Agostino (2008). United States Government Accountability Office GAO Report to Congressional Requesters. Chemical and Biological Defence, DOD and VA Need to Improve Efforts to Identify and Notify Individuals Potentially Exposed during Chemical and Biological Tests, February 2008, GAO-08-366.

[30] Thomas W Sawyer (2020). N-Acetylcysteine as a treatment for sulphur mustard poisoning. Free Radic Biol Med., 161: 305–320. doi: 10.1016/j.freeradbiomed.2020.09.020.

[31] Thomas W. Sawyer, Karin McNeely, Kristen Louis, Pierre Lecavalier, Yanfeng Song, Mercy Villanueva & Robin Clewley (2017). Comparative toxicity of mono- and bifunctional alkylating homologues of sulphur mustard in human skin keratinocytes. Toxicology, 382: 36–46. doi: 10.1016/j.tox.2017.03.005.

Source of Funding:

This study did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.

Competing Interests Statement:

The author declares no competing financial, professional, and personal interests.

Consent for Publication:

Author declares that he consented for the publication of this study.